Reversing Hepatocellular Carcinoma Progression by Using Networked Biological Therapies

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-1619
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Liver-Directed Therapies for Hepatocellular Carcinoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2006English

Phosphoglucomutase 1 Inhibits Hepatocellular Carcinoma Progression by Regulating Glucose Trafficking

PLoS Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2018English

Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Cancer Control
MedicineOncologyHematology
2017English

FOXA1 Inhibits Hepatocellular Carcinoma Progression by Suppressing PIK3R1 Expression in Male Patients

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Histone Acetyl Transferase GCN5 Promotes Human Hepatocellular Carcinoma Progression by Enhancing AIB1 Expression

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2016English

Ferroportin in the Progression and Prognosis of Hepatocellular Carcinoma

European Journal of Medical Research
Medicine
2013English

Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?

British Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy